검색 상세

Evidence based guidelines for the treatment of Helicobacter pylori infection in Korea 2020

  • 주제(키워드) Helicobacter pylori , Guidelines , Treatment , Meta-analysis , Microbial sensitivity tests
  • 주제(기타) Medicine, General & Internal
  • 설명문(일반) [Jung, Hye-Kyung] Ewha Womans Univ, Sch Med, Dept Internal Med, Seoul, South Korea; [Kang, Seung Joo] Seoul Natl Univ Hosp Healthcare, Dept Internal Med, Seoul, South Korea; [Lee, Yong Chan; Kim, Jie-Hyun] Yonsei Univ, Coll Med, Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea; [Yang, Hyo-Joon] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Div Gastroenterol,Dept Internal Med, Seoul, South Korea; [Yang, Hyo-Joon] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Gastrointestinal Canc Ctr, Seoul, South Korea; [Park, Seon-Young] Chonnam Natl Univ, Med Sch, Dept Internal Med, Gwangju, South Korea; [Shin, Cheol Min] Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Seongnam, South Korea; [Kim, Sung Eun] Kosin Univ, Coll Med, Dept Internal Med, Busan, South Korea; [Lim, Hyun Chul] Yonsei Univ, Yongin Severance Hosp, Dept Internal Med, Coll Med, Yongin, South Korea; [Kim, Jie-Hyun] Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea; [Nam, Su Youn] Kyungpook Natl Univ, Chilgok Hosp, Ctr Gastr Canc, Daegu, South Korea; [Shin, Woon Geon] Hallym Univ, Dept Internal Med, Coll Med, Seoul, South Korea; [Park, Jae Myung] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Gastroenterol & Hepatol,Seoul St Marys Hosp, Seoul, South Korea; [Choi, Il Ju] Natl Canc Ctr, Ctr Gastr Canc, Goyang, South Korea; [Kim, Jae Gyu] Chung Ang Univ, Dept Internal Med, Coll Med, Seoul, South Korea; [Choi, Miyoung] Natl Evidence Based Healthcare Collaborating Agcy, Div Healthcare Technol Assessment Res, Seoul, South Korea
  • 등재 SCIE, KCI등재
  • 발행기관 KOREAN ASSOC INTERNAL MEDICINE
  • 발행년도 2021
  • 총서유형 Journal
  • URI http://www.dcollection.net/handler/ewha/000000182233
  • 본문언어 영어
  • Published As http://dx.doi.org/10.3904/kjim.2020.701

초록/요약

Helicobacter pylori infection is one of the most common infectious diseases worldwide. H. pylori is responsible for substantial gastrointestinal morbidity with a high disease burden. Since the revision of the H. pylori Clinical Practice Guidelines in 2013 in Korea, the eradication rate of H. pylori has gradually decreased with the use of a clarithromycin based triple therapy. According to a nationwide randomized controlled study by the Korean College of Helicobacter and Upper Gastrointestinal Research released in 2018, the intention-to-treat eradication rate was only 63.9%, which was mostly due to increased antimicrobial resistance to clarithromycin. The clinical practice guidelines for treatment of H. pylori were updated based on evidence-based medicine from a meta-analysis conducted on a target group receiving the latest level of eradication therapy. The draft recommendations developed based on the meta-analysis were finalized after expert consensus on three recommendations regarding the indication for treatment and eight recommendations on the treatment itself. These guidelines were designed to provide clinical evidence for the treatment of H. pylori to patients, nurses, medical school students, policymakers, and clinicians. These may differ from current medical insurance standards, and will be revised if more evidence emerges in the future.

more